/People

Matthew Hobson

Investor

Analyst at Catalio Capital Management, LP

Baltimore, Maryland

Writes $100K – $5M checks · typically $1.5M

Find your path to Matthew

Sign up to see every warm intro you have to Matthew

  • Paths you didn't know you had: your email and LinkedIn already hold routes to Matthew. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

About

Matthew Hobson is a Principal at Catalio Capital Management, where he focuses on therapeutics and diagnostics investments across the firm's venture and private credit strategies. He joined Catalio at its 2020 founding, having previously been a Postdoctoral Fellow at the Johns Hopkins School of Medicine, where he also earned a PhD in biophysics and biophysical chemistry. He holds a B.S. in chemistry and physics from Emory University.

Contact· self-published, not guessed

Invests in

BiotechDigital Health

Investments

Board seats

Iambic TherapeuticsLassen TherapeuticsOctant TherapeuticsPink Dx

Per the firm's website.

Colleagues at Catalio Capital Management, LP

Frequently asked questions

Who is Matthew Hobson?
Matthew Hobson is a Principal at Catalio Capital Management, where he focuses on therapeutics and diagnostics investments across the firm's venture and private credit strategies. He joined Catalio at its 2020 founding, having previously been a Postdoctoral Fellow at the Johns Hopkins School of Medicine, where he also earned a PhD in biophysics and biophysical chemistry. He holds a B.S. in chemistry and physics from Emory University.
Where does Matthew Hobson work?
Matthew Hobson is Analyst at Catalio Capital Management, LP.
What does Matthew Hobson invest in?
Matthew Hobson invests in Biotech, Digital Health.
What check size does Matthew Hobson write?
Matthew Hobson typically writes checks of $100K – $5M.
What boards does Matthew Hobson sit on?
Matthew Hobson holds tracked board seats at Iambic Therapeutics, Lassen Therapeutics, Octant Therapeutics, Pink Dx.

About this profile. Compiled from public sources — Catalio Capital Management, LP's own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights